Indokem Ltd
INDOKEMIndokem Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is already 60 weeks into its uptrend — timing risk, not thesis risk.
The price is in a confirmed uptrend (60 weeks in). Underneath, the last four quarters read deteriorating — profit −45.2% year on year, and 20% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Indokem Ltd trades at ₹501, in a confirmed uptrend and 60 weeks into that stage. That is −8.3% against its own 200-day average. It sits at 49% of a 52-week range of ₹140 to ₹878. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (5 weeks and counting).
Today the stock is in a confirmed uptrend — week 60 of stage 2, confirmed. At ₹501 it trades −8.3% versus its 200-day average and sits at 49% of its 52-week range (₹140–₹878).
Against the market, two honest reads. Cumulative: over the last 10.0 years the stock moved +11,251% while the NIFTY 500 moved +250% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (5 weeks and counting; last ahead the week of 2026-02-01) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: how the P/E reads against its own history.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Indokem Ltd trades at 262.0× P/E, against too little history to rank. Its long-run median P/E is 358.5×, measured across 0.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 262.0× is against too little history to rank, against a long-run median of 358.5× measured over 0.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Indokem Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 9 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +7.9% | — | — | — |
| Share price | +249.9% | +71.2% | +84.3% | +60.5% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
54.2/100 — rank 5 of 10 in Dyes & Pigments · 51% evidence confidence
Indokem Ltd scores 54.2 out of 100 against the 10 companies it is compared with in Dyes & Pigments, ranking 5. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 19.7 + 9 + 8.9 + 16.6 = 54.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Indokem Ltd reported ₹42.0 Cr of revenue in the Dec 25 quarter, −3.2% year on year. Over 19 years it has compounded at 5.2% a year. The last full year, FY25, came in at ₹178 Cr. The last four reported quarters add to ₹178 Cr.
Indokem Ltd reported ₹42.0 Cr of revenue in the Dec 25 quarter, −3.2% year on year. Over 19 years it has compounded at 5.2% a year. The last full year, FY25, came in at ₹178 Cr. The last four reported quarters add to ₹178 Cr.
FY25 revenue came in at ₹178 Cr (+7.9% on the year), capping 19 years at 5.2% compound. The latest quarter (Dec 25) printed ₹42.0 Cr, −3.2% year on year.
Pace check: the last four quarters averaged +9.5% growth against the decade's 5.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +8.9% over the last 4 quarters against +3.8%/yr over the last 8 — accelerating.
→ Revenue slipped — did margins hold as it scaled? Next: 0.4% this quarter (−2.8 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Indokem Ltd's operating margin is 0.4% in the Dec 25 quarter, −2.8 percentage points against the same quarter a year ago. Across 9 fiscal years the operating margin has ranged −41.0% to 10.0%. The current quarter sits inside that band.
Indokem Ltd's operating margin is 0.4% in the Dec 25 quarter, −2.8 percentage points against the same quarter a year ago. Across 9 fiscal years the operating margin has ranged −41.0% to 10.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 0.4%, −2.8 pp against the same quarter a year ago. Across 9 fiscal years the operating margin has ranged −41.0%–10.0%.
🚨 Why the margin moved: operating margin went −2.8 pp year on year while gross margin went +3.1 pp — the loss came mostly from the gross line: input costs and pricing.
→ Margins slipped — did that reach the bottom line? Next: profit −45.2% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Indokem Ltd earned ₹0.4 Cr of net profit in the Dec 25 quarter, −45.2% year on year. Full-year FY25 profit was ₹3.0 Cr. The 19-year compound rate is 6.0%. That is 1.0% of the quarter's revenue. The same quarter a year earlier earned ₹0.7 Cr. 7 of the last 12 reported quarters were loss-making.
Indokem Ltd earned ₹0.4 Cr of net profit in the Dec 25 quarter, −45.2% year on year. Full-year FY25 profit was ₹3.0 Cr. The 19-year compound rate is 6.0%. That is 1.0% of the quarter's revenue. The same quarter a year earlier earned ₹0.7 Cr. 7 of the last 12 reported quarters were loss-making.
Dec 25 profit was ₹0.4 Cr, −45.2% year on year. On the full year, FY25 printed ₹3.0 Cr (null), and the 19-year compound rate is 6.0%.
→ Profit rose — but did the cash follow? Next: 20% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 20% of Indokem Ltd's reported profit arrived as operating cash — a gap worth watching. In FY25 that was ₹5.0 Cr of operating cash against ₹3.0 Cr of profit. After ₹1.0 Cr of capital spending, ₹4.0 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of ₹5.0 Cr against reported profit of ₹3.0 Cr, leaving free cash of ₹4.0 Cr after ₹1.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 20% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 20%: the cash cycle held roughly steady between FY09 and FY25 — so conversion tracks profitability rather than the cycle. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
→ So follow the cash to where it goes. Next: a 40-day cycle and ₹5.0 Cr of building.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Indokem Ltd's cash conversion cycle runs 40 days in FY25, up from 30 days in FY09. Capital spending ran ₹5.0 Cr over the last 3 years. At FY25 sales of ₹178 Cr each day of that cycle holds about ₹0.5 Cr, so roughly ₹20.0 Cr sits inside the business at any moment.
FY25: debtors at 78 days, inventory at 93 days — roughly 3.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 40 days, looser than FY09's 30.
The full loop: cash goes out to suppliers and production on day 0; stock waits 93 days to sell; customers pay about 78 days after that; and suppliers themselves are paid at 131 days — netting out to the 40-day cycle.
In money terms: at FY25 sales of ₹178 Cr, each day of the cycle holds about ₹0.5 Cr — so the 40-day loop keeps roughly ₹20.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹5.0 Cr over the last 3 fiscal years against ₹8.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 7%.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Indokem Ltd earns a ROCE of 7% in FY25. That is up from a trough of −22% in FY11. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 1.7% net margin on 1.26× asset turns.
FY25 ROCE is 7%, recovered from a FY11 trough of −22% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 1.7% net margin × 1.26× asset turns × 2.27× balance-sheet leverage ≈ 4.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.35.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Indokem Ltd carries ₹22.0 Cr of borrowings against ₹62.0 Cr of equity in FY25, a debt-to-equity of 0.35. Operating profit covers the interest bill 3×. Over 16 years borrowings went from ₹36.0 Cr to ₹22.0 Cr. Capital spending ran ₹5.0 Cr across the last 3 of those years.
FY25: borrowings of ₹22.0 Cr against equity of ₹62.0 Cr — a debt-to-equity of 0.35. Operating profit covers the interest bill 3×. Over 16 years borrowings went from ₹36.0 Cr to ₹22.0 Cr while capital spending ran ₹5.0 Cr in just the last 3 — the build-out is being paid for out of cash, not debt.
→ Who owns this, and are they adding or leaving? Next: the register is quiet.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Indokem Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.0 points over the same window, to 0.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.0 points over 8 quarters to 68.7%; Domestic institutions: +0.0 points over 8 quarters to 0.2%.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Indokem Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Indokem Ltd this page | 262.0× | ₹1,396 Cr | No read | |||
| Atul Ltd | 23.7× | ₹18,865 Cr | Consistent | |||
| Sudarshan Chemical Industries Ltd | 488.0× | ₹8,288 Cr | Mixed | |||
| Kiri Industries Ltd | — | ₹2,643 Cr | No read | |||
| Vidhi Specialty Food Ingredients Ltd | 31.7× | ₹1,551 Cr | Mixed | |||
| Ultramarine & Pigments Ltd | 14.0× | ₹1,108 Cr | Mixed | |||
| Bhageria Industries Ltd | 14.5× | ₹999 Cr | Mixed | |||
| Bodal Chemicals Ltd | 17.9× | ₹857 Cr | No read | |||
| Sudarshan Colorants India Ltd | 17.2× | ₹832 Cr | Mixed | |||
| Sadhana Nitro Chem Ltd | — | ₹812 Cr | No read |
Frequently asked questions
What is Indokem Ltd's share price today?
Indokem Ltd trades at ₹501, +249.9% over the past year. The company is valued at ₹1,396 Cr. The stock sits at 49% of its 52-week range of ₹140–₹878, −8.3% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 60 weeks in. — as of 24 July 2026.
What were Indokem Ltd's latest quarterly results?
Indokem Ltd reported revenue of ₹42.0 Cr and net profit of ₹0.4 Cr for the Dec 25 quarter. Revenue fell 3.2% and profit fell 45.2% year on year. Earnings per share were ₹0.15. The operating margin was 0.4%, 2.8 pp lower than a year earlier. — as of 24 July 2026.
What is Indokem Ltd's revenue?
Indokem Ltd reported revenue of ₹42.0 Cr in the Dec 25 quarter, −3.2% year on year. For the full FY25 fiscal year, revenue was ₹178 Cr (+7.9%). Over the last 19 years revenue compounded at 5.2% a year. — as of 24 July 2026.
What is Indokem Ltd's profit?
Indokem Ltd earned ₹0.4 Cr of net profit in the Dec 25 quarter, −45.2% year on year. Full-year FY25 profit was ₹3.0 Cr. The operating margin ran 0.4% in the latest quarter. — as of 24 July 2026.
What is Indokem Ltd's market cap?
Indokem Ltd's market capitalisation is ₹1,396 Cr at a share price of ₹501. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
Is Indokem Ltd growing?
Not right now — Indokem Ltd's latest numbers are shrinking: latest-quarter revenue −3.2% year on year, profit −45.2%, and the margin −2.8 pp at 0.4%. The 19-year compound rates are 5.2% (revenue) and 6.0% (profit). The earnings engine currently reads: deteriorating — as of 24 July 2026.
How is Indokem Ltd performing?
Indokem Ltd is in a confirmed uptrend, 60 weeks in. Its latest quarter's revenue fell 3.2% and profit fell 45.2% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
Is Indokem Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 60 of stage 2), trading −8.3% versus its 200-day average and at 49% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is Indokem Ltd beating the market?
Not lately — on a trailing-13-week view Indokem Ltd is currently behind the NIFTY 500 (5 weeks and counting; last ahead the week of 2026-02-01), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.0 years the stock moved +11,251% against the NIFTY 500's +250% — ahead of the index over the full window. — as of 24 July 2026.
Will Indokem Ltd's share price go up?
This page publishes no price forecast for Indokem Ltd. What it measures instead: the share price is ₹501, the price is in a confirmed uptrend 60 weeks in. Direction is not something this site claims to know. — as of 24 July 2026.
Who owns Indokem Ltd?
Promoters hold 68.7% of Indokem Ltd, foreign institutions null%, domestic institutions 0.2% and the public 31.1% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 24 July 2026.
Does Indokem Ltd have too much debt?
It is moderate — Indokem Ltd's debt-to-equity is 0.35, and operating profit covers the interest bill 3×. FY25 borrowings were ₹22.0 Cr against equity of ₹62.0 Cr. Read the returns on this page with that leverage in mind — as of 24 July 2026.
What is Indokem Ltd's capex?
Indokem Ltd spent ₹5.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹1.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is Indokem Ltd's cash flow?
Indokem Ltd generated ₹5.0 Cr of operating cash flow in FY25 and ₹4.0 Cr of free cash flow after ₹1.0 Cr of capital spending. Reported profit that year was ₹3.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is Indokem Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 20% of Indokem Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹5.0 Cr against reported profit of ₹3.0 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 24 July 2026.
Where is Indokem Ltd in its business cycle?
Indokem Ltd's FY25 operating margin was 4.0%, against a 9-year band of −41.0%–10.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 0.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the Indokem Ltd story?
Biggest watch item: the price is already 60 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is Indokem Ltd a stock worth studying right now?
This is not investment advice. The machine read: Indokem Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.